Garry Pairaudeau
Chief Tech/Sci/R&D Officer at Exscientia AI Ltd.
Profile
Garry Pairaudeau is currently the Chief Technology Officer at Exscientia AI Ltd.
He previously worked at AstraZeneca PLC as the Head-Hit Discovery from 2017 to 2020.
He also worked as the Chief Technology Officer at Exscientia Plc from 2020 to 2023.
Dr. Pairaudeau received his undergraduate and doctorate degrees from The University of Southampton.
Garry Pairaudeau active positions
| Companies | Position | Start |
|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01/11/2020 |
Former positions of Garry Pairaudeau
| Companies | Position | End |
|---|---|---|
| EXSCIENTIA PLC | Chief Tech/Sci/R&D Officer | 30/06/2023 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/11/2020 |
Training of Garry Pairaudeau
| The University of Southampton | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Private companies | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Garry Pairaudeau
